IP Verse

Georg Kalhammer/stephan Teipel competitive analysis

Latest oppositions filed by Georg Kalhammer/stephan Teipel

Explore patent oppositions filed by Georg Kalhammer/stephan Teipel against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Aug 27, 2026
Patent NumberTitleApplicantOpposition Date
EP2588090
Pharmaceutical Oral Dosage Forms Comprising Dabigatran Etexilate And Its Pharmaceutically Acceptable SaltsKRKAJan 19, 2018
EP2682397
Prodrugs Of Phosphonate Nucleotide Analogues And Methods For Selecting And Making SameGILEAD SCIENCESJan 19, 2018
EP2841431
Dihydrate Of Benzothiophene Compound Or Of A Salt Thereof, And Process For Producing The SameOTSUKA PHARMACEUTICALSep 28, 2017

Latest PTAB cases involving Georg Kalhammer/stephan Teipel

Discover the latest PTAB cases involving Georg Kalhammer/stephan Teipel, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Georg Kalhammer/stephan Teipel with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Aug 27, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
GEORG KALHAMMER/STEPHAN TEIPEL3 - - -
GILEAD SCIENCES53286
KRKA279 - -
KRKA TOVARNA ZDRAVIL - 5 - -